导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.55% | 566/1050 |
| 近一周 | -2.14% | 464/1104 |
| 近一月 | -1.27% | 167/1102 |
| 近一季 | -6.56% | 496/1092 |
| 近半年 | 1.37% | 387/1070 |
| 近一年 | 6.43% | 437/1018 |
| 近两年 | 54.74% | 468/926 |
| 近三年 | 50.45% | 253/834 |
| 成立以来 | 381.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.25% 918/1070 |
21.50% 370/1101 |
- - |
- - |
| 2025 | 28.31% 502/1065 |
1.59% 675/1014 |
1.52% 550/1038 |
19.36% 626/1050 |
4.23% 165/1065 |
| 2024 | 26.35% 41/1011 |
-1.78% 410/960 |
8.94% 23/983 |
23.52% 32/991 |
-4.40% 624/1011 |
| 2023 | -4.06% 182/952 |
8.94% 145/880 |
0.38% 167/895 |
-8.23% 511/915 |
-4.39% 439/952 |
| 2022 | -24.28% 473/867 |
-22.84% 665/773 |
6.56% 431/806 |
-9.37% 205/845 |
1.61% 349/867 |
| 2021 | 37.88% 38/740 |
8.93% 13/580 |
9.11% 385/659 |
5.48% 120/704 |
9.97% 86/740 |
| 2020 | 76.37% 109/554 |
-2.57% 226/419 |
10.36% 398/466 |
29.79% 8/517 |
26.38% 58/554 |
| 2019 | 50.09% 148/410 |
23.47% 813/1146 |
-1.63% 493/1228 |
7.28% 155/390 |
15.19% 53/410 |
| 2018 | -14.78% 26/349 |
- - |
-4.43% 171/990 |
-3.52% 391/1000 |
-5.39% 61/1080 |
| 2017 | 21.82% 77/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 工银物流产业股票A VS. 东吴新产业精选股票A(580008) |